Petra Acquisition, Inc. (PAIC) Adds $12M to Revelation Biosciences Deal

Petra Acquisition, Inc. (PAIC) Adds $12M to Revelation Biosciences Deal

Petra (NASDAQ:PAIC) announced that it had added forward purchase agreements and a convertible note that will add up to $12 million to its combination with biotech firm Revelation. Of this amount, $4.5 million is to be used to backstop potential redemptions with financing from AXA Prime Impact Master Fund, LifeSci Venture Partners as well as
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.